Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment (Q42986429)
Jump to navigation
Jump to search
scientific article published on January 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment |
scientific article published on January 2009 |
Statements
1 reference
Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment (English)
1 reference
Stanislas Pol
1 reference
Martin Marquis
1 reference
George Kukolj
1 reference
Andreas Erhardt
1 reference
Katja Deterding
1 reference
Yves Benhamou
1 reference
Markus Reiser
1 reference
Xavier Forns
1 reference
José Luis Calleja
1 reference
Susanne Ross
1 reference
Hans Christian Spangenberg
1 reference
Javier Garcia-Samaniego
1 reference
Michael Fuchs
1 reference
Jaime Enríquez
1 reference
Johannes Wiegand
1 reference
Jerry Stern
1 reference
Kate Wu
1 reference
Pierre Beaulieu
1 reference
Gerhard Nehmiz
1 reference
Jürgen Steffgen
1 reference
BILB 1941 Study Group
1 reference
1 January 2009
1 reference
1 reference